Total Payments
$9,642
2024 Payments
$457.69
Companies
26
Transactions
513
Medicare Patients
7,390
Medicare Billing
$469,361
Payment Breakdown by Category
Food & Beverage$9,073 (94.1%)
Consulting$520.00 (5.4%)
Education$49.23 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,073 | 503 | 94.1% |
| Consulting Fee | $520.00 | 1 | 5.4% |
| Education | $49.23 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,631 | 54 | $0 (2024) |
| Amgen Inc. | $1,567 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,566 | 147 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $844.44 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $743.94 | 41 | $0 (2024) |
| PFIZER INC. | $458.92 | 25 | $0 (2024) |
| Amarin Pharma Inc. | $448.10 | 23 | $0 (2022) |
| Esperion Therapeutics, Inc. | $337.90 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $260.72 | 14 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $254.02 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $457.69 | 20 | Novartis Pharmaceuticals Corporation ($96.83) |
| 2023 | $736.68 | 38 | Novartis Pharmaceuticals Corporation ($210.48) |
| 2022 | $1,409 | 62 | Amgen Inc. ($390.37) |
| 2021 | $1,627 | 92 | Amarin Pharma Inc. ($248.53) |
| 2020 | $1,748 | 68 | Boehringer Ingelheim Pharmaceuticals, Inc. ($713.17) |
| 2019 | $1,692 | 84 | Amgen Inc. ($464.37) |
| 2018 | $994.36 | 79 | Novartis Pharmaceuticals Corporation ($268.42) |
| 2017 | $977.58 | 70 | Amgen Inc. ($249.24) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $44.29 | General |
| Category: NEUROLOGY | ||||||
| 08/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: Cardiovascular | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Edwards Lifesciences Corporation | PASCAL (Device) | Food and Beverage | In-kind items and services | $38.36 | General |
| Category: Transcatheter Valve Repair | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/27/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: EndoVenous Therapies | ||||||
| 03/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: DIABETES | ||||||
| 01/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardiology | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.67 | General |
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Cardiovascular | ||||||
| 11/16/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,786 | 2,643 | $526,405 | $115,617 |
| 2022 | 10 | 1,847 | 2,685 | $528,218 | $113,062 |
| 2021 | 11 | 1,890 | 2,737 | $550,785 | $123,068 |
| 2020 | 13 | 1,867 | 2,936 | $580,608 | $117,615 |
Total Patients
7,390
Total Services
11,001
Medicare Billing
$469,361
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 567 | 932 | $344,840 | $82,278 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 603 | 962 | $70,226 | $9,534 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $37,026 | $8,070 | 21.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 150 | 150 | $37,800 | $7,362 | 19.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 51 | 51 | $13,821 | $2,935 | 21.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 181 | 202 | $4,646 | $1,697 | 36.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 56 | 56 | $4,312 | $908.89 | 21.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 51 | $3,978 | $806.73 | 20.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 14 | 15 | $4,395 | $792.26 | 18.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 56 | 56 | $2,856 | $607.75 | 21.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 89 | $1,335 | $373.80 | 28.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 13 | 13 | $1,170 | $251.51 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 575 | 936 | $346,320 | $81,385 | 23.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 586 | 928 | $67,744 | $8,739 | 12.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 163 | 163 | $41,076 | $7,819 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $26,928 | $5,626 | 20.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 81 | 81 | $21,951 | $4,792 | 21.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 99 | 99 | $7,623 | $1,643 | 21.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 91 | 91 | $4,641 | $1,038 | 22.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 19 | 19 | $5,567 | $945.45 | 17.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 165 | 196 | $4,508 | $580.68 | 12.9% |
| 85610 | Blood test, clotting time | Office | 2022 | 20 | 124 | $1,860 | $492.00 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 527 | 912 | $337,440 | $82,761 | 24.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 207 | 208 | $52,416 | $11,000 | 21.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 570 | 945 | $68,985 | $9,549 | 13.8% |
About Dr. Robert Hoff, MD
Dr. Robert Hoff, MD is a Internal Medicine healthcare provider based in Sandy Springs, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659388908.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hoff, MD has received a total of $9,642 in payments from pharmaceutical and medical device companies, with $457.69 received in 2024. These payments were reported across 513 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($9,073).
As a Medicare-enrolled provider, Hoff has provided services to 7,390 Medicare beneficiaries, totaling 11,001 services with total Medicare billing of $469,361. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology, Cardiovascular Disease
- Location Sandy Springs, GA
- Active Since 08/01/2006
- Last Updated 06/06/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659388908
Products in Payments
- Repatha (Biological) $1,312
- ENTRESTO (Drug) $1,196
- PRADAXA (Drug) $1,082
- ELIQUIS (Drug) $937.87
- XARELTO (Drug) $844.44
- JARDIANCE (Drug) $549.12
- Vascepa (Drug) $448.10
- LEQVIO (Drug) $369.60
- NEXLETOL (Drug) $337.90
- VERQUVO (Drug) $260.72
- Livalo (Drug) $254.02
- Corlanor (Drug) $242.78
- CoreValve Evolut (Device) $180.21
- MULTAQ (Drug) $166.02
- Edarbi (Drug) $163.16
- CAMZYOS (Drug) $92.01
- VYNDAQEL (Drug) $89.83
- PRALUENT (Drug) $86.97
- WATCHMAN (Device) $78.60
- Circulatory Support (Device) $55.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sandy Springs
Dr. Sharon Tinanoff, Md, MD
Internal Medicine — Payments: $8,857
Internal Medicine $8,857
Charles Cohn, Md, MD
Internal Medicine — Payments: $8,447
Internal Medicine $8,447
Dr. You Sun Nam, Md, MD
Internal Medicine — Payments: $869.27
Internal Medicine $869.27
Dr. David Dubose, M.d, M.D
Internal Medicine — Payments: $656.14
Internal Medicine $656.14
Dr. Catherine Dekle, M.d, M.D
Internal Medicine — Payments: $463.86
Internal Medicine $463.86
Hafsa Majeed, Mbbs, Md, MBBS, MD
Internal Medicine — Payments: $390.19
Internal Medicine $390.19